These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2896638)

  • 1. Conformation of D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Pen-Thr-NH2 (CTP-NH2), a highly selective mu-opioid antagonist peptide, by 1H and 13C n.m.r.
    Pelton JT; Whalon M; Cody WL; Hruby VJ
    Int J Pept Protein Res; 1988 Feb; 31(2):109-15. PubMed ID: 2896638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors.
    Kazmierski W; Wire WS; Lui GK; Knapp RJ; Shook JE; Burks TF; Yamamura HI; Hruby VJ
    J Med Chem; 1988 Nov; 31(11):2170-7. PubMed ID: 2903246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
    Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
    J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
    Kazmierski WM; Ferguson RD; Knapp RJ; Lui GK; Yamamura HI; Hruby VJ
    Int J Pept Protein Res; 1992 May; 39(5):401-14. PubMed ID: 1358847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
    Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton n.m.r. investigation of conformational influence of penicillamine residues on the disulfide ring system of opioid receptor selective somatostatin derivatives.
    Sugg EE; Tourwe D; Kazmierski W; Hruby VJ; Van Binst G
    Int J Pept Protein Res; 1988 Feb; 31(2):192-200. PubMed ID: 2896639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A topographical model of mu-opioid and brain somatostatin receptor selective ligands. NMR and molecular dynamics studies.
    Kazmierski WM; Ferguson RD; Lipkowski AW; Hruby VJ
    Int J Pept Protein Res; 1995; 46(3-4):265-78. PubMed ID: 8537180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic somatostatin analogues as potent antagonists at mu-, but not delta- and kappa-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain.
    Mulder AH; Wardeh G; Hogenboom F; Kazmierski W; Hruby VJ; Schoffelmeer AN
    Eur J Pharmacol; 1991 Nov; 205(1):1-6. PubMed ID: 1687463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2: a potent and selective antagonist opioid receptors.
    Gulya K; Lui GK; Pelton JT; Kazmierski W; Hruby VJ; Yamamura HI
    NIDA Res Monogr; 1986; 75():209-12. PubMed ID: 2893264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8.
    Mattern RH; Zhang L; Rueter JK; Goodman M
    Biopolymers; 2000 May; 53(6):506-22. PubMed ID: 10775066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
    Landis G; Lui G; Shook JE; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1989 Mar; 32(3):638-43. PubMed ID: 2537426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
    Shook JE; Pelton JT; Wire WS; Hirning LD; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Mar; 240(3):772-7. PubMed ID: 2882015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
    Hawkins KN; Knapp RJ; Lui GK; Gulya K; Kazmierski W; Wan YP; Pelton JT; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1989 Jan; 248(1):73-80. PubMed ID: 2563293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonist activity of the cyclic somatostatin analogue CTP at mu- but not delta- and kappa-opioid receptors involved in presynaptic inhibition of neurotransmitter release.
    Mulder AH; Wardeh G; Kazmierski W; Hruby VJ
    Eur J Pharmacol; 1988 Nov; 157(1):109-14. PubMed ID: 2906879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of conformational properties of linear and cyclic delta selective opioid ligands DTLET (Tyr-D X Thr-Gly-Phe-Leu-Thr) and DPLPE (Tyr-c[D X Pen-Gly-Phe-Pen]) by 1H n.m.r. spectroscopy.
    Belleney J; Roques BP; Fournie-Zaluski MC
    Int J Pept Protein Res; 1987 Sep; 30(3):356-64. PubMed ID: 3692682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.